Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Souqiyyeh MZ and Shaheen FA | Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209438 |
| Zolezzi M | Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209437 |
| pmid:18208026 | ||||
| Al-Saran KA and Sabry AA | Pregnancy in dialysis patients: a case series. | 2008 | J Med Case Rep | pmid:18205953 |
| Al-Mueilo SH | Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. | 2005 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18202490 |
| Pai AB et al. | Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study. | 2007 | Clin Ther | pmid:18201586 |
| Wall GC and Pauly RA | Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. | 2008 | Am J Health Syst Pharm | pmid:18192261 |
| Hasegawa K et al. | [Improvement of urinary d-glucaric acid assay and its application]. | 2008 | Yakugaku Zasshi | pmid:18176065 |
| pmid:18118003 | ||||
| Liu Z et al. | Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. | 2008 | Nucl Med Commun | pmid:18094633 |
| Roth S et al. | Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. | 2008 | Transl Res | pmid:18061126 |
| Franco G et al. | Behaviour of urinary D-glucaric acid excretion in surgical patients and anaesthesiology staff acutely exposed to isoflurane and nitrous oxide. | 1991 Nov-Dec | Med Lav | pmid:1803214 |
| pmid:17994454 | ||||
| Wang S et al. | Chemical reactions of vitamin C with intravenous-iron formulations. | 2008 | Nephrol. Dial. Transplant. | pmid:17951305 |
| Francis GS and Kanderian A | Anemia and heart failure a new pathway? | 2007 | J. Am. Coll. Cardiol. | pmid:17950148 |
| Toblli JE et al. | Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. | 2007 | J. Am. Coll. Cardiol. | pmid:17950147 |
| Teschke O et al. | Quorum sensing detected by atomic force microscopy imaging of corrals surrounding multicellular arrangement of bacteria. | 2008 | Microsc. Res. Tech. | pmid:17943987 |
| Saluk-Juszczak J et al. | Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. | 2008 | Nutr Metab Cardiovasc Dis | pmid:17933501 |
| Sato K | [Drug-induced osteomalacia]. | 2007 | Clin Calcium | pmid:17906405 |
| Olas B et al. | D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. | 2008 | Cell Biol. Toxicol. | pmid:17846905 |
| Malindretos P et al. | Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. | 2007 | Am. J. Nephrol. | pmid:17804904 |
| Singh J and Gupta KP | Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. | 2007 | J. Environ. Pathol. Toxicol. Oncol. | pmid:17725531 |
| Grzegorzewska AE | [Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease]. | 2007 | Pol. Arch. Med. Wewn. | pmid:17722476 |
| Breymann C | Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. | 2005 | J Med Assoc Thai | pmid:17718296 |
| Vindal V et al. | GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. | 2007 | BMC Genomics | pmid:17714599 |
| Tryfinopoulou P et al. | Diversity of Shewanella population in fish Sparus aurata harvested in the Aegean Sea. | 2007 | J. Appl. Microbiol. | pmid:17714405 |
| Zager RA | Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. | 2006 | Clin J Am Soc Nephrol | pmid:17699373 |
| Bishu K and Agarwal R | Acute injury with intravenous iron and concerns regarding long-term safety. | 2006 | Clin J Am Soc Nephrol | pmid:17699372 |
| Singh H et al. | Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. | 2006 | Clin J Am Soc Nephrol | pmid:17699248 |
| Thomas J and Martinez A | Blood conservation in the critically ill. | 2007 | Am J Health Syst Pharm | pmid:17687066 |
| Shaheen FA et al. | Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. | 2002 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:17660651 |
| Reed J et al. | The safety of intravenous iron sucrose use in the elderly patient. | 2007 | Consult Pharm | pmid:17658969 |
| Yew WS et al. | Evolution of enzymatic activities in the enolase superfamily: L-talarate/galactarate dehydratase from Salmonella typhimurium LT2. | 2007 | Biochemistry | pmid:17649980 |
| Vikrant S | Optimum dosage regimen for iron sucrose. | 2007 | Kidney Int. | pmid:17625585 |
| Agarwal R et al. | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2007 | Kidney Int. | pmid:17622274 |
| Auerbach M and Rodgers GM | Intravenous iron. | 2007 | N. Engl. J. Med. | pmid:17611217 |
| Herzberg M et al. | Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory. | 1977 | Isr. J. Med. Sci. | pmid:17578 |
| pmid:17577885 | ||||
| Breborowicz A et al. | Peritoneal effects of intravenous iron sucrose administration in rats. | 2007 | Transl Res | pmid:17543848 |
| Sav T et al. | Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? | 2007 | Ren Fail | pmid:17497463 |
| Iversen C et al. | The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. | 2007 | BMC Evol. Biol. | pmid:17439656 |
| Sane R et al. | Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. | 2007 | Pharmacotherapy | pmid:17381390 |
| Ranfaing E | [Treatments of the martial deficiencies: preparations available in France]. | 2006 | Nephrol. Ther. | pmid:17373280 |
| Beck-da-Silva L et al. | Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. | 2007 | J. Card. Fail. | pmid:17338998 |
| George P et al. | Coronary artery vasospasm with iron sucrose. | 2007 | Nephrol. Dial. Transplant. | pmid:17327282 |
| Marsillach J et al. | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17324148 |
| pmid:17322190 | ||||
| Pai AB et al. | Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. | 2007 | Pharmacotherapy | pmid:17316146 |
| Breymann C et al. | Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. | 2007 | J Perinat Med | pmid:17302514 |
| Izuel Rami M et al. | [Budget impact analysis of a blood saving program for urgent traumatological surgery]. | 2007 | Med Clin (Barc) | pmid:17266885 |